top of page

DR. SANDEEP RAI

(Phd)

E-mail: sandeeprai82@gmail.com

 

 

PUBLICATIONS:

  • Endothelial colony forming cell (ECFC) tetrahydrobiopterin level in coronary artery disease patients and its association with circulating endothelial progenitor cells" has been submitted to the Canadian Journal of Physiology and Pharmacology

  • Analysing “tear-drop” prints of acute promyelocytic leukemia (APML): immunophenotypic prognostication of APML by FCM. Fouzia Siraj, Pranay Tanwar, Amitabh Singh, Bhavika Rishi, Amar Ranjan, Anita Chopra, , Sameer Bakhshi, Aroonima Misra: Am J Blood Res 2021;11(4):446-457.

  • Pediatric malignancy or Acquired pure red cell aplasia- Diagnostic dilemma in pediatric case. submitted to AJBR

  • Hypocellular AML versus MDS-diagnostic challenge case report with review of literature. submitted to AJBR

  • Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL. (2021). https://doi.org/10.1007/s00277-021-04580-2

  • Therapeutic lessons from transfusion in pregnancy-effect on hematological parameters and coagulation profile. Sunanda Chauhan, Bhavika Rishi, Pranay Tanwar, Ghazala Mehdi, Sayeedul Hasan Arif, Tamkeen Rabbani, , Fouzia Siraj, Aroonima Misra:. Am J Blood Res 2021;11(3):303-316

  • Rai S, Singh S, Gupta R. Prognostic significance of CD56 and CD7 in acute myeloid leukaemia and their outcome. Am J Blood Res. 2020 Aug 25;10(4):109-117. PMID: 32923090; PMCID: PMC7486483..

  • Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sharma A, Kumar L. A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML. Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):e673-e684. doi: 10.1016/j.clml.2020.05.004. Epub 2020 May 11. PMID: 32561191.

  • Rai S, Singh S, Gupta R. Levels of expression of CD45 for normal lymphocytes in different leukemic cases by flowcytometry. Indian J Pathol Microbiol. 2020 Jul-Sep;63(3):505-506. doi: 10.4103/IJPM.IJPM_188_19. PMID: 32769357.

  • Misra A, Chauhan S, Tanwar P, Singh S, Sharma S. Real-Time Compensation in Flow Cytometry: A Real Need of Time. Indian J Hematol Blood Transfus. 2018 Jul;34(3):585-588. doi: 10.1007/s12288-018-0914-4. Epub 2018 Jan 10. PMID: 30127585; PMCID: PMC6081326.

  • Rai S, Bhardwaj U, Misra A, Singh S, Gupta R. Comparison between photostability of Alexa Fluor 448 and Alexa Fluor 647 with conventional dyes FITC and APC by flow cytometry. Int J Lab Hematol. 2018 Jun;40(3):e52-e54. doi: 10.1111/ijlh.12809. Epub 2018 Mar 25. PMID: 29575796.

  • Rai S, Bhardwaj U, Singh S, Misra A. Effect of processing time on analysis of rare event in minimal residual disease study. Indian J Pathol Microbiol. 2017 Jul-Sep;60(3):449-451. doi: 10.4103/IJPM.IJPM_353_16. PMID: 28937402.

  • Bhardwaj U, S Rai . Correlation of MRD status and relapse in acute myeloidleukemia. Bhardwaj et al., Int J Med Lab Res, 2016, 1(1): 2-8.

  • Soni S, Chopra A, Bakhshi S, Vishwanath A, Verma D, , Kumar R. Prognostic impact of CD56 in pediatric AML. Int J Lab Hematol. 2015 Dec;37(6):e157-9. doi: 10.1111/ijlh.12402. Epub 2015 Jul 6. PMID: 26147745.

  • Chopra A, Bakhshi S, Pramanik SK, Pandey RM, Singh S, Gajendra S, Gogia A, Chandramohan J, Sharma A, Kumar L, Seth R, , Kumar R. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL. Eur J Haematol. 2014 Mar;92(3):211-8. doi: 10.1111/ejh.12238. Epub 2014 Jan 10. PMID: 24329989.

  • Somasundaram V, Soni S, Chopra A, , Mahapatra M, Kumar R, Pati H. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome. Int J Lab Hematol. 2016 Apr;38(2):141-50. doi: 10.1111/ijlh.12458. Epub 2016 Jan 29. PMID: 26822549.

  • Jaiswal AK, Sidhu A , Determination of Cetrizine from blood using thin layer chromatography, Institution of chemist (India), 2013.

 

Ph.D Thesis:

Significance of CD7 and CD56 in detection of Minimal Residual Disease in Acute Myeloid Leukemia by multiparameter Flow Cytometry. Also correlate expression with the molecular status (FLT3-ITD, NPM1, CBF and AML-ETO), cytogenetic prognosis (favorable, intermediate and unfavorable overall survival and relapse free survival rate and hazard ratio for OS, RFS, LFS in all groups.

 

AWARDS:

 

BD biosciences and The Cytometry Society- India Present BD-TCS Award in clinical research category for 2014 to the paper " Immunophenotypic analysis of T-Acute Lymphoblastic Leukemia. A CD5 Based ETP-ALL perspective of Non ETP-ALL".

 

 

WORKSHOP AND CONFERENCES:

  • TCS Annual Meeting 2018 from 29-30 October, 2018. Organized by: Laboratory Oncology Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, AIIMS, New Delhi

  • CME SERIES ON HEMATO-ONCOPATHOLOGY 23rd -24th JULY, 2016. Organized by: Laboratory Oncology Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, AIIMS, New Delhi

  • 7th Annual Meeting of The Cytometry Society and 15th Indo-US Clinical Cytometry Workshop October 25 -27, 2014 at IRCH, AIIMS, New Delhi

  • APHCON-2014, 29-30 March 2014, PGIMER, Dr Ram Manohar Lohia Hospital, New Delhi, India

  • “First  3 day work shop for the technologists for ICICLE trial on the 12-14 January 2015 at TMH, Mumbai.”

  • “Multicolor Immunophenotyping: Standardization & Application” March 2012 at Tata Memorial Hospital ,Mumbai

  • RGCON 2011 workshop ,Feb 2011 organized byRajiv Gandhi Cancer Institute & Research Centre, Delhi.

 

IMG-20190117-WA0017.jpg
bottom of page